This information was published on 2026-03-27T11:24 for IP Right Registration Published.
| Field | Value |
| (210) | 2605268 (IR 1887653) |
| (220) |
17 Oct 2025
|
| (300) |
EM, 12 Jun 2025, 019201789
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 1
Chemicals used in science; stem cells for research purposes; stem cells for scientific purposes; cell growth media for growing cells for scientific use; biological preparations [other than for medical use]; cultures of cell media [other than for medical or veterinary use]. Class 42 Science and technology services; medical and scientific research services; scientific research and development; medical and pharmacological research services; laboratory services; analytical laboratory services; scientific services relating to the isolation and cultivation of human tissues and cells; consultancy in the field of scientific research; advisory services relating to scientific research; providing information about industrial analysis and research services; research laboratories; provision of information relating to scientific research; research and development of new products for others; scientific research for medical purposes; laboratory research services relating to pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; research and development in the field of microorganisms and cells; clinical trials; culturing of cells for scientific research purposes; stem cell research; quality control and authentication services; providing scientific research information in the field of genetics; providing medical research information in the field of genetics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information about the results of clinical trials for pharmaceutical products; pharmaceutical research services; development of pharmaceutical preparations and medicines; pharmaceutical products development. |
| (540) | NEXTCELL |
| (550) | Word |
| (730) |
NextCell Pharma AB
|
| (750) |
Davies Collison Cave Pty Ltd
|
Find out more about publications on the About page.